Cystic fibrosis: The miracle drugs priced out of reach
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
CNN anchor Sara Sidner shared on Monday that she is currently undergoing treatment for stage 3 breast cancer. Sidner, 51, announced her diagnosis during an emotional segment of “CNN News Central,” which she co-hosts. Sidner told viewers she is in her second month of chemotherapy and will undergo radiation and a double mastectomy. “I have…
Looking to reduce your exposure to plasticizers in the new year? Contrary to what you might think, shopping organic and avoiding plastic food packaging isn’t a surefire way to avoid harmful chemicals such as BPA and phthalates. According to new research from Consumer Reports, phthalates and bisphenols — two chemicals linked to various health risks such as…
Health 11 July 2023, 5:39 pm 1 minute Reuters exclusively reported that Only about one-third of patients prescribed a popular weight-loss drug like Novo Nordisk’s (NOVOb.CO) Wegovy were still taking it a year later, while total healthcare costs for the group rose sharply. Market Impact Shares of the Danish drugmaker fell 2.3% on Tuesday. Article…
The coronavirus pandemic resulted in a lot of loss — and to this day people may be losing out because of it. A mental health phenomenon dubbed the “pandemic skip” has caught viral attention on social media. The hosts of the podcast “Between Us Girlies” revealed their understanding of the concept in a TikTok video,…
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….